Literature DB >> 19749093

miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221.

Ai Kotani1, Daon Ha, James Hsieh, Prakash K Rao, Diana Schotte, Monique L den Boer, Scott A Armstrong, Harvey F Lodish.   

Abstract

MLL-AF4 acute lymphocytic leukemia (ALL) has a poor prognosis. MicroRNAs (miRNA) are small noncoding RNAs that posttranscriptionally regulate expression of target mRNAs. Our analysis of previously published data showed that expression of miR-128b and miR-221 is down-regulated in MLL-rearranged ALL relative to other types of ALL. Reexpression of these miRNAs cooperatively sensitizes 2 cultured lines of MLL-AF4 ALL cells to glucocorticoids. Target genes down-regulated by miR-128b include MLL, AF4, and both MLL-AF4 and AF4-MLL fusion genes; miR-221 down-regulates CDKN1B. These results demonstrate that down-regulation of miR-128b and miR-221 is implicated in glucocorticoid resistance and that restoration of their levels is a potentially promising therapeutic in MLL-AF4 ALL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19749093      PMCID: PMC2774553          DOI: 10.1182/blood-2008-12-191619

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  37 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression.

Authors:  James J-D Hsieh; Emily H-Y Cheng; Stanley J Korsmeyer
Journal:  Cell       Date:  2003-10-31       Impact factor: 41.582

Review 3.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

Review 4.  Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.

Authors:  C-H Pui; J M Chessells; B Camitta; A Baruchel; A Biondi; J M Boyett; A Carroll; O B Eden; W E Evans; H Gadner; J Harbott; D O Harms; C J Harrison; P L Harrison; N Heerema; G Janka-Schaub; W Kamps; G Masera; J Pullen; S C Raimondi; S Richards; H Riehm; S Sallan; H Sather; J Shuster; L B Silverman; M G Valsecchi; E Vilmer; Y Zhou; P S Gaynon; M Schrappe
Journal:  Leukemia       Date:  2003-04       Impact factor: 11.528

5.  Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts.

Authors:  N Rivard; G L'Allemain; J Bartek; J Pouysségur
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

6.  MicroRNAs modulate hematopoietic lineage differentiation.

Authors:  Chang-Zheng Chen; Ling Li; Harvey F Lodish; David P Bartel
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

7.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

8.  Interaction of AF4 wild-type and AF4.MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology?

Authors:  Adelheid Bursen; Sven Moritz; Anne Gaussmann; Sören Moritz; Theo Dingermann; Rolf Marschalek
Journal:  Oncogene       Date:  2004-08-19       Impact factor: 9.867

9.  Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein.

Authors:  C Caslini; A Serna; V Rossi; M Introna; A Biondi
Journal:  Leukemia       Date:  2004-06       Impact factor: 11.528

10.  CD19-targeting liposomes containing imatinib efficiently kill Philadelphia chromosome-positive acute lymphoblastic leukemia cells.

Authors:  Masamitsu Harata; Yasushi Soda; Kenzaburo Tani; Jun Ooi; Tomoko Takizawa; Minghan Chen; Yuansong Bai; Kiyoko Izawa; Seiichiro Kobayashi; Akira Tomonari; Fumitaka Nagamura; Satoshi Takahashi; Kaoru Uchimaru; Tohru Iseki; Takashi Tsuji; Tsuneo A Takahashi; Kanji Sugita; Shinpei Nakazawa; Arinobu Tojo; Kazuo Maruyama; Shigetaka Asano
Journal:  Blood       Date:  2004-05-20       Impact factor: 22.113

View more
  42 in total

Review 1.  Implication of microRNAs in drug resistance for designing novel cancer therapy.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Dejuan Kong; Shadan Ali
Journal:  Drug Resist Updat       Date:  2010-03-17       Impact factor: 18.500

Review 2.  miRNAs in normal and malignant B cells.

Authors:  Ai Kotani; Ratanakanit Harnprasopwat; Takae Toyoshima; Toyotaka Kawamata; Arinobu Tojo
Journal:  Int J Hematol       Date:  2010-07-08       Impact factor: 2.490

Review 3.  MicroRNAs and other non-coding RNAs as targets for anticancer drug development.

Authors:  Hui Ling; Muller Fabbri; George A Calin
Journal:  Nat Rev Drug Discov       Date:  2013-11       Impact factor: 84.694

4.  Bone Marrow Microenvironment Niche Regulates miR-221/222 in Acute Lymphoblastic Leukemia.

Authors:  Blake S Moses; Rebecca Evans; William L Slone; Debbie Piktel; Ivan Martinez; Michael D Craig; Laura F Gibson
Journal:  Mol Cancer Res       Date:  2016-06-29       Impact factor: 5.852

5.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

Review 6.  MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals.

Authors:  Mansi A Parasramka; Emily Ho; David E Williams; Roderick H Dashwood
Journal:  Mol Carcinog       Date:  2011-07-07       Impact factor: 4.784

Review 7.  The effects of microRNAs on glucocorticoid responsiveness.

Authors:  Huimin Wang; Xuxu Gou; Tang Jiang; Juan Ouyang
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-12       Impact factor: 4.553

8.  MicroRNA-142-3p inhibits cell proliferation in human acute lymphoblastic leukemia by targeting the MLL-AF4 oncogene.

Authors:  Liping Dou; Jingxin Li; Dehua Zheng; Yonghui Li; Xiaoning Gao; Chengwang Xu; Li Gao; Lili Wang; Li Yu
Journal:  Mol Biol Rep       Date:  2013-09-22       Impact factor: 2.316

Review 9.  Circadian clocks, epigenetics, and cancer.

Authors:  Selma Masri; Kenichiro Kinouchi; Paolo Sassone-Corsi
Journal:  Curr Opin Oncol       Date:  2015-01       Impact factor: 3.645

10.  Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia.

Authors:  Alex H Beesley; Janelle L Rampellini; Misty-Lee Palmer; Jasmin Y S Heng; Amy L Samuels; Martin J Firth; Jette Ford; Ursula R Kees
Journal:  Mol Cancer       Date:  2010-10-28       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.